New Delhi, April 11 -- Connecticut, which is leading a multistate investigation of an anti-trust lawsuit against 18 generic pharma companies, including five Indian firms, over price cartelisation on Wednesday said it has unsealed some key details of possibly the "largest cartel case in the history of the United States". Initials and titles of individuals implicated in the conspiracy, industry "code words" and previously undisclosed emails from drug companies "brazenly discussing strategy to violate federal and state antitrust laws" have been uncovered, the Office of Attorney General of Connecticut that filed this suit in said.
The Indian generic makers named in the lawsuit are Aurobindo, Dr Reddy's, Emcure, Glenmark, and Zydus. The other g...